BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 16, 2009
 |  BC Week In Review  |  Company News  |  Other News

Cubist, Teva infectious news

Cubist plans to file a patent infringement suit against Teva, which submitted an ANDA to FDA for a generic version of Cubist's Cubicin daptomycin....

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >